REDUCEDT+30
Ali Asif
Protagonist Therapeutics Inc · NASDAQ
−46,034 sh · $6.5M
Filed 2 Oct 2026SEC Form 4view source
BlackRock
13F filer
$199.5M
5,758,112 sh
Duquesne Family Office
13F filer
$25.6M
208,900 sh
Soros Fund Management
13F filer
$8.7M
100,000 sh
Polen Capital Management
13F filer
$2.8M
22,651 sh
Bridgewater Associates
13F filer
$556.1K
5,276 sh
Ali Asif
Protagonist Therapeutics Inc · NASDAQ
−46,034 sh · $6.5M
Ali Asif
Protagonist Therapeutics Inc · NASDAQ
+9,229 sh · $359.7K
Ali Asif
Protagonist Therapeutics Inc · NASDAQ
+5,312 sh · $64.6K
Ali Asif
Protagonist Therapeutics Inc · NASDAQ
−12,595 sh · $1.8M
Ali Asif
Protagonist Therapeutics Inc · NASDAQ
+28,438 sh · $666.0K
Ali Asif
Protagonist Therapeutics Inc · NASDAQ
+15,650 sh · $300.3K
Patel Dinesh V PH D
Protagonist Therapeutics Inc · NASDAQ
−54,174 sh · $7.9M
Patel Dinesh V PH D
Protagonist Therapeutics Inc · NASDAQ
−7,278 sh · $1.0M
Patel Dinesh V PH D
Protagonist Therapeutics Inc · NASDAQ
+54,174 sh · $1.2M
Patel Dinesh V PH D
Protagonist Therapeutics Inc · NASDAQ
+63,548 sh · $1.4M